21-Aminosteroids block neutrophil infiltration and provide liver protection independent of NO2/-/NO3/- levels

Journal of Surgical Research

Volumn 66, Issue 2, 1996, Pages 131-137

  Palma Vargas, J M ^a   Toledo, A H ^a   Garcia Criado F J ^a   Misawa, K ^a   Lopez Neblina F ^a,b   Toledo Pereyra, L H ^a,b,c  

^a Surg Res Inst at Borgess Med C   (United States)

^b WESTERN MICHIGAN UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 AMINOSTEROID; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; LAZAROID; LIVER ENZYME; MYELOPEROXIDASE; NITRATE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; SURVIVAL;

EID: 0030515261     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0384     Document Type: Article

References (33)

1. 1. Braughler, J. M., Pregenzer, J. F., Chase, R. L., et al. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J. Biol. Chem. 262: 1143, 1987.
2. 2. Tamara, J. A., Hernandez, M. C., Toledo-Pereyra, L. H., et al. Avances en el manejo de la lesión de isquemia/reperfusión, con referencia a los 21 aminoesteroides. Rev. Fac. Med. UNAM 33: 383, 1990.
3. 3. Hall, E. D., and Travis, M. A. Inhibition of arachidonic acid-induced vasogenic brain edema by the non-glucocorticoid 21-aminosteroid U74006F. Brain Res. 451: 350, 1988.
4. 4. Young, W., Wojak, J. C., and DeCrescito, V. 21-Aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia. Stroke 19: 1013, 1988.
5. 5. Hall, E. D., Pazzara, K. E., Braughler, J. M., et al. 21-Aminosteroid lipid peroxidation inhibition U-74006F protects against cerebral ischemia in gerbils. Stroke 19: 997, 1988.
6. 6. Podrazik, R. M., Obedian, R. S., Remick, D. G., et al. Attenuation of structural and functional damage from acute renal ischemia by the 21-amino steroid U74006F in rats. Curr. Surg. 46: 287, 1989.
7. 7. Holzgrefe, H. H., Buchanan, L. V., and Gibson, J. K. Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium. J. Cardiovasc. Pharmacol. 15: 239, 1990.
8. 8. Hernández, M. C., Tamara, J. A., Toledo-Pereyra, et al. Acute mesenteric small bowel ischemia in the rat: Effect of the 21-aminosteroid U-74006F. Res. Surg. 3: 10, 1991.
9. 9. Hernández, M. C., Walters, W., and Toledo-Pereyra, L. H. Effect of a 21-aminosteroid and or adenosine in the ischemic rat liver. Transplant Proc. 2428, 1991.
10. 10. Ovize, M., Lorgeril, M., Ovize, A., et al. U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarct size in a canine model of myocardial ischemia reperfusion. Am. Heart J. 122: 681, 1991.
11. 11. Stone, W. C., Bjorling, D. E., Southard, J. H., et al. Evaluation of intestinal villus height in rats after ischemia and reperfusion by administration of superoxide dismutase, polyethylene glycol-conjugated superoxide dismutase, and two 21-aminosteroids. Am. J. Vet. Res. 53: 2153, 1992.
12. 12. Stanley, J. J., Goldblum, J. R., Frank, T. S., et al. Attenuation of renal reperfusion injury in rats by the 21-aminosteroid U74006F. J. Vasc. Surg. 685, 1993.
13. 13. Killinger, W. A., Dorofi, D. B., Keagy, B. A., et al. Improvement of endothelial cell viability at 4°C by addition of lazaroid U74500A to preservation solutions. Transplantation 53: 983, 1992.
14. 14. Aeba, R., Killinger, W. A., Keenan, R. J., et al. Lazaroid U74500A as an additive to University of Wisconsin solution for pulmonary grafts in the rat transplant model. J. Thorac. Cardiovasc. Surg. 104: 1333, 1992.
15. 15. Hendry, P. J., Anstadt, M. P., Plunkett, M. D., et al. Improved donor myocardial recovery with a new lazaroid lipid antiperoxidant in the isolated canine heart. J. Heart Lung Transplant. 11: 636, 1992.
16. 16. Jacobsson, J., Sundberg, R., Rilo, H. L., et al. Protective effects of the lazaroid U74500A and lidoflazine on liver preservation with UW solution. Transplant. Int. 6: 281, 1993.
17. 17. Gadaleta, D., Verma, M., and Davis, J. M. Inhibition of neutrophil leukotriene generation by the 21-aminosteroid, U-74389F. J. Surg. Res. 57: 233, 1994.
18. 18. Currin, R. T., Reinstein, L. J., Lichtman, S. N., et al. Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury. Transplant. Proc. 25: 1631, 1993.
19. 19. Di Rosa, M., Radomski, M., Carnuccio, R., et al. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172: 1246, 1990.
20. 20. Moncada, S. The L-arginine: Nitric oxide pathway. Acta Physiol. Scand. 145: 201, 1992.
21. 21. Suzuki, S., Toledo-Pereyra, L. H., Rodriguez, F. J., et al. Physiopathologic advantages of portosystemic shunting for studies of total hepatic ischemia and reperfusion injury in the rat. Transplantology 3: 96, 1992.
22. 22. Bradley, P. P., Priebat, D. A., Christensen, R. D., et al. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206, 1982.
23. 23. Mullane, K. M., Kraemer, R., and Smith, B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 14: 157, 1985.
24. 24. Suzuki, S., Toledo-Pereyra, L. H., Rodriguez, F. J., et al. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. J. Surg. Res. 57: 253, 1994.
25. 25. Kubes, P., Suzuki, M., and Granger, D. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651, 1991.
26. 26. Gauthier, T., Davenpeck, K., and Lefer, A. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am. J. Physiol. 269: G562, 1994.
27. 27. Lopez-Neblina, F., Paez, A. J., and Toledo-Pereyra, L. H. Modulation of neutrophil infiltration through nitric oxide in the ischemic rat kidney. Transplant. Proc. 27: 1883, 1995.
28. 28. DiRosa, M., Radomski, R., Carniccio, R., et al. Glucocorticoids inhibit the induction of Nitric Oxide Synthase in Macrophages. Biochem. Biophys. Res. Com. 172: 1246, 1990.
29. 29. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051, 1992.
30. 30. Xie, Q., and Nathan, C. The high output nitric oxide pathway: Role and regulation. J-Leukocyte Biol. 56: 576, 1994.
31. 31. Roderberg, D. A., Chaet, M. S., Bass, R. C., et al. Nitric oxide: An overview. Am. J. Surg. 170: 292, 1995.
32. 32. Todo, S., Hamada, N, Zhu, Y., et al. Lazaroids for 48 hour canine liver preservation. Transplantation 61: 189, 1996.
33. 33. Jaeschke, H., Bautista, A. P., Spolarics, Z., et al. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia. J. Leukocyte Biol. 52: 377, 1992.